Sort   by:  
 Page size 
UnknownPhase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
Not available
S-EPMC4021043 | biostudies-literature
Genomicsena-DATASET-SC-21-07-2014-10:55:39:527-89 - samples
NSCLC targeted.
EGAD00001000889 | EGA
Genomicsena-DATASET-SC-21-07-2014-10:52:30:961-88 - samples
NSCLC WGS.
EGAD00001000888 | EGA
Genomicsena-DATASET-GENE-CAO-08-02-2016-11:04:25:039-253 - samples
Multi-region Illumina whole-exome and/or whole-genome sequencing on tumor regions collected from early-stage NSCLC patients who underwent definitive surgical resection prior to receiving adjuvant therapy. Patients covered by this dataset: L012, L013, L015, L017
EGAD00001001918 | EGA
Genomicsena-DATASET-TRACERX-25-07-2014-12:27:19:910-271 - samples
Multi-region Illumina whole-exome and/or whole-genome sequencing on tumor regions collected from early-stage NSCLC patients who underwent definitive surgical resection prior to receiving adjuvant therapy. Detected variants were validated on Ion AmpliSeq™ Custom Panel and/or Comprehensive Cancer Gen...
EGAD00001000900 | EGA
GenomicsTRACERx: TRAcking non-small cell lung Cancer Evolution through therapy (Rx). Pilot Study. Multi-region sequencing of early-stage NSCLCs.
Deciphering the complexity of non-small cell lung cancer (NSCLC) evolutionary histories may elucidate the basis for its dismal outcome. We performed multi-region sequencing of early-stage NSCLCs. Spatial dissection revealed branched tumor evolution, with driver mutations occurring before and after s...
EGAS00001000809 | EGA
GenomicsSpatial and temporal diversity in genomic instability processes define early stage lung cancer evolution.
Deciphering the complexity of non-small cell lung cancer (NSCLC) evolutionary histories may elucidate the basis for its dismal outcome. We performed multi-region sequencing on 25 regions from seven early-stage NSCLCs. Spatial dissection revealed branched tumor evolution, with driver mutations occurr...
EGAS00001000840 | EGA
GenomicsWTSI CGP Data access committee
Data Access Committee EGAC00001000000
EGAC00001000000 | EGA
GenomicsTRACERx Pilot Study Data Access Committee
Data Access Committee EGAC00001000198
EGAC00001000198 | EGA
UnknownBody Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.
Not available
S-EPMC5065111 | biostudies-literature
Sort   by:  
 Page size